Abstract

Aging is accompanied by inexorable loss of muscle tissue. One of the underlying causes for this is the massive change in the hormonal milieu of the body. The role of a female sex steroid - estrogen - in these processes is frequently neglected, although the rapid decline in its production coincides with a steep deterioration in muscle performance. We recruited 54- to 62-year-old monozygotic female twin pairs discordant for postmenopausal hormone replacement therapy (HRT, n=11 pairs; HRT use 7.3 ± 3.7 years) from the Finnish Twin Cohort to investigate the association of long-term, estrogen-based HRT with skeletal muscle transcriptome. Pathway analysis of muscle transcript profiles revealed significant HRT-induced up-regulation of a biological process related to regulation of cell structure and down-regulation of processes concerning, for example, cell-matrix interactions, energy metabolism and utilization of nutrients (false discovery rate < 0.15). Lending clinical relevance to the findings, these processes explained a significant fraction of the differences observed in relative proportion of muscle within thigh and in muscle performance (R(2) =0.180-0.257, P=0.001-0.023). Although energy metabolism was affected through down-regulation of the transcripts related to succinate dehydrogenase complex in mitochondria, no differences were observed in mtDNA copy number or oxidative capacity per muscle cross section. In conclusion, long-term use of HRT was associated with subtle, but significant, differences in muscle transcript profiles. The better muscle composition and performance among the HRT users appeared to be orchestrated by improved regulatory actions on cytoskeleton, preservation of muscle quality via regulation of intramuscular extracellular matrix and a switch from glucose-oriented metabolism to utilization of fatty acids.

Highlights

  • Natural menopause refers to a state in which normal menstruation spontaneously ceases for 12 consecutive months at 45– 55 years of age (McKinlay et al, 1992)

  • Eleven monozygotic (MZ) twin pairs discordant for estrogenbased Hormone replacement therapy (HRT) aged 57.6 ± 1.8 years formed the present study sample, a subgroup of our previous publication (Ronkainen et al, 2009)

  • The HRT users had higher levels of both total and free 17b-estradiol (E2) and total estrone compared to their sisters not on HRT (Table 1)

Read more

Summary

Introduction

Natural menopause refers to a state in which normal menstruation spontaneously ceases for 12 consecutive months at 45– 55 years of age (McKinlay et al, 1992). The cessation of ovaries to produce estrogens leads to several types of symptoms and consequences, which increase the risk of deterioration of health and decrease quality of life. Some reports have provided sound evidence for a link between accelerated decline in muscle strength and the occurrence of menopause (Kallman et al, 1990; Phillips et al, 1993; Samson et al, 2000). Regardless of the cause, low muscle strength is a significant predictor of adverse health events (Rantanen et al, 2003) as well as mobility limitation and disability (Rantanen et al, 1999). Adequate muscle performance is an important factor responsible for preventing falls and consequent fractures. Sufficient muscle mass itself is of high importance as skeletal muscle is the primary reservoir of amino acids and serves as a major site for various metabolic activities contributing to glucose balance and lipid metabolism of the whole body (Nader, 2005; Zurlo et al, 1990)

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call